Početna › Mezoteliom › Texas
Kliničke studije za Mezoteliom u državi Texas
19 studija za Mezoteliom traži sudionike na lokacijama u državi Texas.
Gradovi u državi Texas
Službeni tekst studije (engleski)
SW-682 in Advanced Solid Tumors
- Mary Crowley Research Center US Oncology, Dallas
- U.T. MD Anderson Cancer Center, Houston
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06251310Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma
- Baylor St Lukes, Houston
U tijeku regrutacijaFaza 1/2Zdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT05932199A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- START Dallas Fort Worth, Fort Worth
- MD Anderson, Houston
- NEXT Oncology Houston, Houston
- i još 1
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07277413A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
- NEXT Oncology, San Antonio
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 18. ruj 2026. · NCT07705334Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
- NEXT Oncology - Austin, Austin
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 16. ruj 2026. · NCT06566079TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma
- The University of Texas MD Anderson Cancer Center, Houston
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 15. ruj 2026. · NCT04969315Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT05732831Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
- Ut Southwestern, Dallas
- Texas Oncology - DFW, Fort Worth
- MDACC, Houston
- i još 2
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 2. ruj 2026. · NCT05245500Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- USOR Texas Oncology, Abilene
- Texas Oncology - Central / South Texas, Austin
- Mary Crowley Cancer Research, Dallas
- i još 3
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 4. kol 2026. · NCT05579366Lead-212 PSV359 Therapy for Patients With Solid Tumors
- MD Anderson Cancer Center, Houston
U tijeku regrutacijaFaza 1/2
Od 18 do 90 godina · Oba spola · Ažurirano 6. srp 2026. · NCT06710756SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
- MD Anderson Cancer Center, Houston
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 24. lip 2026. · NCT05568680CT-95 in Advanced Cancers Associated With Mesothelin Expression
- Context Investigational Site, San Antonio
- Context Investigational Site, San Antonio
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 12. lip 2026. · NCT06756035A 2-part Phase 1/2 Open-label Trial on ODM-212
- NEXT Oncology, Irving
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 4. svi 2026. · NCT07563738A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
- MD Anderson Cancer Center, Houston
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 13. tra 2026. · NCT06362369A Study of VET3-TGI in Patients With Solid Tumors
- Mary Crowley Cancer Research, Dallas
- University of Texas MD Anderson Cancer Center, Houston
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 7. tra 2026. · NCT06444815Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
- MD Anderson Cancer Center, Houston
- NEXT Oncology, San Antonio
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 2. tra 2026. · NCT04665206VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- The University of Texas MD Anderson Cancer Center (site 127), Houston
U tijeku regrutacijaFaza 1/2
Od 18 do 80 godina · Oba spola · Ažurirano 11. pro 2025. · NCT03556228A Study of NX-1607 in Adults With Advanced Malignancies
- MD Anderson Cancer Center, Houston
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2025. · NCT05107674A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors
- MD Anderson Cancer Center, Houston
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 9. kol 2024. · NCT06452160Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.